JNCI-Journal of the National Cancer Institute-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2020-04-19 xusongluan

这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？

169 3

展开3条回复

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-12-10 jfazj

最近大家有人在上面发过文章么？能否分享一下经验

306 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-09-13 寒雪傲梅d38f0753

这个和annals of oncology哪个好中一点啊

352 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-07-08 sunliang

厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表::
接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表:
年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.

hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.

266 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-07-05 hfdfg

审稿速度:2.0 | 投稿命中率:25.0
经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.

302 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-07-03 sunliang

很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表:
博士.结果怎么样?

Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?

311 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-05-20 ms9821035889741998

审稿速度:2.0 | 投稿命中率:5.0
经验分享：transmission of human pathogenic virus causes cancers
cured by the traditional chinese medicine
chief author：ke-yu，etc.

58 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-03-14 Leopard FD

兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表::
2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表:
2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.

156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.

227 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2018-01-07 Surgery

2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。

277 0

[GetPortalCommentsPageByObjectIdResponse(id=589253, encodeId=7bcb58925391, content=这个期刊是不是需要提交后所有作者邮件填表确认，才能进行下一步？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=169, replyNumber=3, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/Q0j4TwGTfTJVvosCkAibo90yEX02pDl69yDP3IrN2V5LQow02IcXDxNiayMZIib7gdSxDTsovv5hIXWLVDm5H9sdg/132, createdBy=7a712141795, createdName=xusongluan, createdTime=Sun Apr 19 00:00:00 CST 2020, time=2020-04-19, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=564260, encodeId=783c564260bd, content=最近大家有人在上面发过文章么？能否分享一下经验, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=306, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=26b81522186, createdName=jfazj, createdTime=Mon Dec 10 11:50:00 CST 2018, time=2018-12-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=561044, encodeId=36de561044e5, content=这个和annals of oncology哪个好中一点啊, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=352, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=51ac1707479, createdName=寒雪傲梅d38f0753, createdTime=Thu Sep 13 22:46:00 CST 2018, time=2018-09-13, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=559005, encodeId=28a055900576, content=厉害啊.这杂志也能灌水?看来是大佬啊 hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运.hfdfg 2018-07-05 14:06:00 发表: 年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=hfdfg 2018-07-05 发表:: 接收率:约25% 审稿时间:约2个月年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., objectType=tool_impact_factor, channel=null, level=null, likeNumber=266, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Sun Jul 08 00:00:00 CST 2018, time=2018-07-08, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558902, encodeId=624e55890287, content=审稿速度:2.0 | 投稿命中率:25.0 经验分享：年初有幸灌水一篇.17.8投稿.两天送审.两月回来大修.三个reviewer.其中一个统计reviewer.问了一共50几个问题.一一认真回答(文章看的非常细.对数据非常仔细).一月后小修.再一个月格式修改.今年2月顺利接收.两周后在线.总体来说杂志效率非常高.而且不要版面费.想法够新可以试试.预祝各位好运., beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=302, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=e1572395988, createdName=hfdfg, createdTime=Thu Jul 05 14:06:00 CST 2018, time=2018-07-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=558823, encodeId=24c85588239e, content=很经典的杂志.能发一篇也很厉害啦Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, beContent=Dr. H 2018-03-17 00:00:00 发表: 博士.结果怎么样?, objectType=tool_impact_factor, channel=null, level=null, likeNumber=311, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/08/15/af911bdd940ac5430dfecaae1ba3bfff.jpg, createdBy=75e41936661, createdName=sunliang, createdTime=Tue Jul 03 00:00:00 CST 2018, time=2018-07-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=843235, encodeId=a446843235df, content=审稿速度:2.0 | 投稿命中率:5.0 经验分享：transmission of human pathogenic virus causes cancers cured by the traditional chinese medicine chief author：ke-yu，etc. , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=58, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f7f15414091, createdName=ms9821035889741998, createdTime=Sun May 20 14:21:38 CST 2018, time=2018-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=553654, encodeId=e6b055365402, content=兄台.文章咋样了156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中.Surgery 2018-01-07 13:50:00 发表: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., beContent=156euXm8119(暂无昵称) 2018-01-07 发表:: 2017年12月6日投稿.1周送外审.2018年1月6日显示Review Complete...焦灼的等待中., objectType=tool_impact_factor, channel=null, level=null, likeNumber=227, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://cdnapi.center.medsci.cn/medsci/head/2017/07/27/31563fd376b0b5aa161e1b65a468d912.jpg, createdBy=237c2098756, createdName=Leopard FD, createdTime=Wed Mar 14 00:00:00 CST 2018, time=2018-03-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550858, encodeId=45b7550858ca, content=2017年12月6日投稿，1周送外审，2018年1月6日显示Review Complete。。。焦灼的等待中。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=277, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Jan 07 13:50:00 CST 2018, time=2018-01-07, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=550302, encodeId=1c3e55030282, content=mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=353, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=70f72231001, createdName=Surgery, createdTime=Sun Dec 24 18:44:00 CST 2017, time=2017-12-24, status=1, ipAttribution=)]

2017-12-24 Surgery

mark一下，12月6日投稿，12月14日送外审，等待中。。。希望可以！

353 0

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务